Fully Online Care
In-House RxDose Adjustments By Provider
Prescription IncludedYes
Telehealth IncludedYes
Online-Only OptionYes
Skip LabsNot Disclosed
- Flat-rate pricing · All-inclusive pricing
- No commitment required · Cancel anytime
- Prescription included · 100% online · Dose adjustment supported · Free consultation
- Free shipping · Supplies included · Discreet packaging
- Tirzepatide, Semaglutide
- Auto-renewing plans
- Pharmacy data not disclosed
- Not available in all states
Provider Plans
Monthly Plan
TirzepatideMonthly
$397/avg
PharmacyNot Disclosed (503A)
AdditivesNot Disclosed
PreservativeBenzyl Alcohol
Based on 503A
BUD (Shelf Life)90 Days
Based on 503A
BillingMonthly
CommitmentNo Commitment
Other FeesNo Extra Fees
Auto-RenewsYes
| DoseYour Supply | Your Price | Your Supply | Avg/mo | Your Value |
|---|---|---|---|---|
| 2.2mg/wk9mg/mo | $397.00 | 9mg | $397 | $45.11/mg |
| 4.4mg/wk18mg/mo | $397.00 | 18mg | $397 | $22.56/mg |
| 6.6mg/wk26mg/mo | $397.00 | 26mg | $397 | $15.04/mg |
| 8.8mg/wk35mg/mo | $397.00 | 35mg | $397 | $11.28/mg |
| 11.0mg/wk44mg/mo | $397.00 | 44mg | $397 | $9.02/mg |
| 13.2mg/wk53mg/mo | $397.00 | 53mg | $397 | $7.52/mg |
| Non-standard FDA doses | ||||
States Excluded From PlanAL · AR · CA · MS
Oral Daily Plan
TirzepatideMonthlyOral
$349/avg
PharmacyNot Disclosed (503A)
AdditivesNot Disclosed
PreservativeNot Disclosed
BUD (Shelf Life)Not Disclosed
BillingMonthly
CommitmentNo Commitment
Other FeesNo Extra Fees
Auto-RenewsYes
| DoseYour Supply | Your Price | Your Supply | Avg/mo | Your Value |
|---|---|---|---|---|
| -- | $349.00 | -- | $349 | N/A |
States Excluded From PlanAL · AR · CA · MS
Provider Details
Self-Pay
Insurance AcceptedNo
HSA/FSA AcceptedNot Disclosed
Financing AvailableNot Disclosed
LegitScript Certified
LegitScript CertifiedYes
HIPAA CompliantYes
Mobile AppNot Disclosed
Free Shipping
Supplies IncludedCold-Packed
Free ShippingYes
Expedited ShippingNo
Discreet PackagingYes
Tirz + Sema · 503A
Formats: Injection · Oral Tablet
Offers TirzepatideYes
Offers SemaglutideYes
Offers BrandNo
Other TreatmentsYes
Contact & Support
Live Chat
Provider Notes
Compliance
The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.